Anzeige
Mehr »
Login
Samstag, 28.09.2024 Börsentäglich über 12.000 News von 691 internationalen Medien
Von 0,059 € auf 0,26 €: Die Gold-Aktie, die alle Erwartungen übertrifft
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1WYY8 | ISIN: US64112L2034 | Ticker-Symbol:
Branche
Internet
Aktienmarkt
Sonstige
1-Jahres-Chart
NET SAVINGS LINK INC Chart 1 Jahr
5-Tage-Chart
NET SAVINGS LINK INC 5-Tage-Chart
ACCESSWIRE
282 Leser
Artikel bewerten:
(1)

Net Savings Link Inc: NSAV Announces Save-The-Date for VIP Event

LONDON, UNITED KINGDOM / ACCESSWIRE / June 21, 2024 / Net Savings Link, Inc. (OTC Pink:NSAV), a leading Web3, blockchain and digital asset technology company, announced today a Save-The-Date for a VIP event on July 26, 2024, in Downtown Nashville, TN. The specific location will be provided to approved attendees on July 10, 2024, via email and direct message on TheAlley.io. Entrance to the event will require an event NFT, provided at no cost to the participants.

Event Details:

• Date: Friday, July 26, 2024
• Location: Confidential
• Time: 10:00 AM to 10:00 PM
• Sponsors: NSAVx.com, NSAVPay, TheAlley.io, DiVinciPay, EVERESTlpp.com and special sponsors to be announced

Included (All Sit-Down Meals):

• Full Breakfast
• Full Lunch Menu
• Full Dinner Menu with open bar from 5:00 PM to 8:00 PM

Speakers: 20 VIP speakers will share their knowledge on topics including DEX, CEX, utility tokens, 501c3 tokens, taxation, legal regulations, meme coins, specific projects, and project tokens.

Broadcasting: The event will be recorded by TheAlley.io and broadcasted on TheAlleyTV.com.

Audience Capacity: The event will accommodate 150 attendees, including up to 50 NSAVx VIP shareholders. VIP shareholders' tickets will be awarded on a first-come, first-served basis. To be placed on the VIP list, candidates must fill out the form at https://www.thealley.io/vipevent VIP enrollment begins on June 21, 2024, and ends on July 10, 2024.

Kevin Simon, CEO of NSAV, stated, "Having attended the most recent Austin crypto events, I witnessed firsthand areas that needed our improvement, as well as the importance of connecting face-to-face with our shareholders, funding partners, and potential projects. This will be the first of many events we are going to roll out across the country to better connect with the people who have tasked us with building NSAV, while also sharing our story with the general public to educate consumers on the importance of using crypto in real life."

About Net Savings Link, Inc.: NSAV's vision is the establishment of a fully integrated technology company, which provides turnkey technological solutions to the Web3, blockchain and digital asset industries. The Company drives innovation in the digital currency space by developing advanced blockchain technologies, digital assets, and market solutions that bridge the gap between traditional business frameworks and the future of decentralized technology. Over time, the Company plans to provide a wide range of services such as software solutions, e-commerce, financial services, advisory services and information technology.

For further information please contact NSAV at info@nsavholdinginc.com

For further information please contact NSAVx.com at hello@nsavxmail.com

The NSAV corporate website can be accessed at https://www.netsavingslinkinc.com

The NSAV CEX website can be accessed at https://nsavx.com/

TheAlley.io can be accessed at https://www.thealley.io

The AirdropX.co website can be accessed at https://www.airdropx.co/

The Swopx.io website can be accessed at https://www.swopx.io

The NSAV Stock information website can be accessed at https://www.nsavstock.com

The NSAVx Token website can be accessed at https://www.nsavxtoken.com/nsavx-token

The NSAVx Discord Server can be accessed at https://discord.com/invite/7Q2Vv5NmKd

The NSAV Twitter account can be accessed at https://twitter.com/nsav_tech

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that, all forward-looking statements involve risks and uncertainties, including without limitation, the ability of Net Savings Link, Inc. to accomplish its stated plan of business. Net Savings Link, Inc. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward- looking statements included herein, the inclusion of such information should not be regarded as a representation by Net Savings Link, Inc. or any other person.

Contact

Net Savings Link, Inc.
info@nsavholdinginc.com

Media Contact

Organization: Net Savings Link Inc
Contact Person: James Tilton
Website: https://www.nsavholdinginc.com
Email: info@nsavholdinginc.com
Contact Number: +17185698815
Address: 26 Grosvenor Street, Mayfair
Address 2: W1K4QW
City: London
Country: United Kingdom

SOURCE: Net Savings Link Inc.



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.